BIOXYTRAN, INC (BIXT)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312021-Mar-312020-Dec-312020-Sep-302020-Jun-302020-Mar-312019-Dec-312019-Sep-302019-Jun-302019-Mar-312018-Dec-312018-Sep-302018-Jun-302018-Mar-312017-Dec-312017-Sep-302017-Jun-302017-Mar-312016-Dec-312016-Sep-302016-Jun-302016-Mar-312015-Dec-312015-Sep-302015-Jun-302015-Mar-312014-Dec-312014-Sep-302014-Jun-30
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q1-FY2021Q4-FY2020Q3-FY2020Q2-FY2020Q1-FY2020Q4-FY2019Q3-FY2019Q2-FY2019Q1-FY2019Q4-FY2018Q3-FY2018Q2-FY2018Q1-FY2018Q4-FY2017Q3-FY2017Q2-FY2017Q1-FY2017Q4-FY2016Q3-FY2016Q2-FY2016Q1-FY2016Q4-FY2015Q3-FY2015Q2-FY2015Q1-FY2015Q4-FY2014Q3-FY2014Q2-FY2014
Operating Cash Flow(236,971$)(41,474$)(80,687$)(167,323$)(127,937$)(73,547$)(70,265$)(109,567$)(92,626$)(342,576$)(153,284$)(186,889$)(391,100$)(890,831$)4,343$(55,715$)(156,789$)(185,598$)(32,053$)(73,652$)(139,730$)(188,625$)16,227$5$(80$)110$(3,398$)(8,042$)(7,681$)(3,937$)(11,738$)(19,033$)(13,166$)21,546$(7,629$)(3,438$)(17,258$)8,456$(46,468$)
Investing Cash Flow(6,240$)(1,674$)(15,162$)(15$)(12,071$)(10,821$)693$(5,995$)(6,561$)(12,693$)(20,336$)(4,711$)(8,953$)
Purchases of Property and Equipment
Financing Cash Flow738,626$54,503$94,645$166,532$110,490$105,518$73,070$99,500$45,000$390,361$65,000$50,000$450,000$941,886$(41,886$)50,000$31,052$322,000$20,000$0$222,250$0$(400$)0$0$25,000$25,000$(10,675$)7,800$0$0$
End Cash Position23,448$3,050$11,092$18,773$22,710$9,448$3,481$11,647$776$2,730$6,168$15,626$7,170$
Exchange Rate Effect
Dividends Paid
Unlevered Free Cash Flow(236,971$)(41,474$)(80,687$)(167,323$)(127,937$)(73,547$)(70,265$)(109,567$)(92,626$)(342,576$)(153,284$)(186,889$)(391,100$)(890,831$)4,343$(55,715$)(156,789$)(185,598$)(32,053$)(73,652$)(139,730$)(188,625$)16,227$5$(80$)110$(3,398$)(8,042$)(7,681$)(3,937$)(11,738$)(19,033$)(13,166$)21,546$(7,629$)(3,438$)(17,258$)8,456$(46,468$)